Abstract
Non-melanoma skin cancer (NMSC) is the most frequent malignancy in the United States, with over one million new cases reported annually. Approximately 80% of NMSC are basal cell carcinomas (BCC), while the remaining 20% of NMSC are squamous cell carcinomas (SCC). BCC and SCC commonly arise in regions of the skin subjected to chronic sun exposure implicating ultraviolet radiation (UV)-induced cellular damage as the primary causative agent. While surgical excision is an effective treatment of NMSC, strategies aimed at NMSC prevention have not been exploited clinically. The application of sunscreens has been the primary means of prevention by physically blocking the absorption of UV radiation. However, sunscreens have had limited success in decreasing NMSC incidence overall, necessitating more targeted strategies against UV damage. In this review we will discuss the relevance of recently identified UVinduced cellular changes, including induction of reactive oxygen species, immune modulation, and damage to mitochondrial DNA to serve as potential targets for the chemoprevention of NMSC. Finally, we will discuss the potential of genes required for the maintenance of epithelial stem cells in the skin as therapeutic targets for cutaneous cancer.
Keywords: Non melanoma skin cancer, ultraviolet radiation, reactive oxygen species, inflammation, stem cell, keratinocyte
Current Cancer Therapy Reviews
Title: Squamous Cell Carcinoma of the Skin: Current Strategies for Treatment and Prevention
Volume: 5 Issue: 1
Author(s): Michael A. Bachelor and David M. Owens
Affiliation:
Keywords: Non melanoma skin cancer, ultraviolet radiation, reactive oxygen species, inflammation, stem cell, keratinocyte
Abstract: Non-melanoma skin cancer (NMSC) is the most frequent malignancy in the United States, with over one million new cases reported annually. Approximately 80% of NMSC are basal cell carcinomas (BCC), while the remaining 20% of NMSC are squamous cell carcinomas (SCC). BCC and SCC commonly arise in regions of the skin subjected to chronic sun exposure implicating ultraviolet radiation (UV)-induced cellular damage as the primary causative agent. While surgical excision is an effective treatment of NMSC, strategies aimed at NMSC prevention have not been exploited clinically. The application of sunscreens has been the primary means of prevention by physically blocking the absorption of UV radiation. However, sunscreens have had limited success in decreasing NMSC incidence overall, necessitating more targeted strategies against UV damage. In this review we will discuss the relevance of recently identified UVinduced cellular changes, including induction of reactive oxygen species, immune modulation, and damage to mitochondrial DNA to serve as potential targets for the chemoprevention of NMSC. Finally, we will discuss the potential of genes required for the maintenance of epithelial stem cells in the skin as therapeutic targets for cutaneous cancer.
Export Options
About this article
Cite this article as:
Bachelor A. Michael and Owens M. David, Squamous Cell Carcinoma of the Skin: Current Strategies for Treatment and Prevention, Current Cancer Therapy Reviews 2009; 5 (1) . https://dx.doi.org/10.2174/157339409787314090
DOI https://dx.doi.org/10.2174/157339409787314090 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Anti-cancer Actions of Vitamin D
Anti-Cancer Agents in Medicinal Chemistry Context-dependent Action of Transforming Growth Factor β Family Members on Normal and Cancer Stem Cells
Current Pharmaceutical Design Genetics and Bioenergetics of Mitochondria Influencing the Etiology and Pharmacology of Steroidal Hormones
Current Pharmacogenomics Plant Natural Products in Anticancer Drug Discovery
Current Organic Chemistry Anticancer Potential of Thiazole Derivatives: A Retrospective Review
Mini-Reviews in Medicinal Chemistry Roles of Laminin-332 and α6β4 Integrin in Tumor Progression
Mini-Reviews in Medicinal Chemistry Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets Novel Strategies and Tools for Enhanced Sensitivity in Routine Biomolecule Analytics
Current Pharmaceutical Analysis Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Pleiotropic Effects of Cardioactive Glycosides
Current Medicinal Chemistry Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
Current Medicinal Chemistry Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways
Current Pharmaceutical Design Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism